Skip to search formSkip to main contentSkip to account menu

cisplatin/ifosfamide/muramyl tripeptide phosphatidylethanolamine liposome

Known as: CDDP/IFF/MTP-PE Liposome, Cisplatin/Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract: Centipede has been prescribed for the treatment of cardiovascular diseases in Asian countries for several hundred years… 
2001
2001
Lipopolysaccharide (LPS)‐induced intestinal endotoxaemia perturbs motility and causes activation and influx of inflammatory cells… 
Highly Cited
1995
Highly Cited
1995
In order to examine the intestinal expression of the recently cloned H+/di-tripeptide transporter (PepT1), oligonucleotide probes… 
1992
1992
We have investigated the effect of a combined chemoimmunotherapy protocol with liposomal muramyl tripeptide… 
1992
1992
Summary A series of peptide aldehydes synthetized in our institute during the last 15 years were screened to detect their… 
1989
1989
C-reactive protein (CRP) delivered in liposomes [CRP-multilamellar vesicles (MLV)] has been demonstrated to inhibit lung and… 
1987
1987
The purpose of these studies was to determine whether the oral administration of a lipophilic analog of muramyl dipeptide, MTP-PE… 
1986
1986
The purpose of these studies was to determine whether the combination of a low-dose local thoracic irradiation (LTI) followed by…